Trinity Biotech plc (TRIB)
USD 0.81
(-4.35%)
USD 0.81
(-4.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 19.45 Million USD | -16.07% |
| 2022 | 22.04 Million USD | -42.1% |
| 2021 | 38.07 Million USD | -21.62% |
| 2020 | 48.58 Million USD | 27.44% |
| 2019 | 38.12 Million USD | -8.03% |
| 2018 | 41.44 Million USD | -1.05% |
| 2017 | 41.88 Million USD | -2.79% |
| 2016 | 43.09 Million USD | -6.82% |
| 2015 | 46.24 Million USD | -8.15% |
| 2014 | 50.34 Million USD | 9.66% |
| 2013 | 45.91 Million USD | 8.66% |
| 2012 | 42.25 Million USD | 5.3% |
| 2011 | 40.12 Million USD | -8.69% |
| 2010 | 43.94 Million USD | -22.93% |
| 2009 | 57.01 Million USD | -8.77% |
| 2008 | 62.49 Million USD | 13.11% |
| 2007 | 55.24 Million USD | 8.79% |
| 2006 | 50.78 Million USD | 7.63% |
| 2005 | 47.18 Million USD | 17.2% |
| 2004 | 40.25 Million USD | 22.74% |
| 2003 | 32.79 Million USD | 28.06% |
| 2002 | 25.61 Million USD | 35.38% |
| 2001 | 18.91 Million USD | 16.04% |
| 2000 | 16.3 Million USD | 24.56% |
| 1999 | 13.08 Million USD | 48.72% |
| 1998 | 8.8 Million USD | 49.15% |
| 1997 | 5.9 Million USD | 247.06% |
| 1996 | 1.7 Million USD | -22.73% |
| 1995 | 2.2 Million USD | 175.0% |
| 1994 | 800 Thousand USD | 300.0% |
| 1993 | 200 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.51 Million USD | 14.79% |
| 2024 Q1 | 4.99 Million USD | 21.62% |
| 2023 Q1 | 5.57 Million USD | -10.63% |
| 2023 Q4 | 4.1 Million USD | -4.04% |
| 2023 Q3 | 4.28 Million USD | -14.91% |
| 2023 Q2 | 5.03 Million USD | -9.74% |
| 2023 FY | 18.5 Million USD | -16.07% |
| 2022 Q2 | 6.52 Million USD | -10.22% |
| 2022 Q4 | 6.23 Million USD | 209.48% |
| 2022 FY | 22.04 Million USD | -42.1% |
| 2022 Q1 | 7.27 Million USD | 0.43% |
| 2022 Q3 | 2.01 Million USD | -69.13% |
| 2021 Q4 | 7.23 Million USD | -18.66% |
| 2021 Q1 | 10.91 Million USD | -30.3% |
| 2021 Q3 | 8.9 Million USD | -19.29% |
| 2021 FY | 38.07 Million USD | -21.62% |
| 2021 Q2 | 11.02 Million USD | 1.04% |
| 2020 Q2 | 6.87 Million USD | -25.93% |
| 2020 FY | 48.58 Million USD | 27.44% |
| 2020 Q3 | 16.77 Million USD | 144.16% |
| 2020 Q1 | 9.27 Million USD | 0.02% |
| 2020 Q4 | 15.65 Million USD | -6.67% |
| 2019 FY | 38.12 Million USD | -8.03% |
| 2019 Q2 | 9.43 Million USD | 1.06% |
| 2019 Q1 | 9.33 Million USD | -8.76% |
| 2019 Q4 | 9.27 Million USD | -7.91% |
| 2019 Q3 | 10.07 Million USD | 6.72% |
| 2018 Q1 | 10.42 Million USD | 2.42% |
| 2018 Q3 | 9.98 Million USD | -7.65% |
| 2018 Q4 | 10.23 Million USD | 2.53% |
| 2018 Q2 | 10.8 Million USD | 3.64% |
| 2018 FY | 41.44 Million USD | -1.05% |
| 2017 FY | 41.88 Million USD | -2.79% |
| 2017 Q2 | 10.81 Million USD | 9.38% |
| 2017 Q3 | 10.99 Million USD | 1.65% |
| 2017 Q4 | 10.18 Million USD | -7.42% |
| 2017 Q1 | 9.89 Million USD | 4.35% |
| 2016 Q3 | 11.66 Million USD | -1.26% |
| 2016 FY | 43.09 Million USD | -6.82% |
| 2016 Q2 | 11.81 Million USD | 16.63% |
| 2016 Q1 | 10.13 Million USD | -5.91% |
| 2016 Q4 | 9.47 Million USD | -18.75% |
| 2015 Q1 | 12.1 Million USD | -4.47% |
| 2015 FY | 46.24 Million USD | -8.15% |
| 2015 Q3 | 11.98 Million USD | 5.2% |
| 2015 Q2 | 11.39 Million USD | -5.84% |
| 2015 Q4 | 10.76 Million USD | -10.16% |
| 2014 FY | 50.34 Million USD | 9.66% |
| 2014 Q1 | 12.16 Million USD | -5.13% |
| 2014 Q4 | 12.66 Million USD | -2.65% |
| 2014 Q3 | 13.01 Million USD | 4.01% |
| 2014 Q2 | 12.5 Million USD | 2.86% |
| 2013 Q4 | 12.81 Million USD | 5.65% |
| 2013 Q1 | 10.33 Million USD | -1.86% |
| 2013 FY | 45.91 Million USD | 8.66% |
| 2013 Q3 | 12.13 Million USD | 14.24% |
| 2013 Q2 | 10.62 Million USD | 2.74% |
| 2012 FY | 42.25 Million USD | 5.3% |
| 2012 Q4 | 10.53 Million USD | -0.98% |
| 2012 Q3 | 10.63 Million USD | -0.93% |
| 2012 Q2 | 10.73 Million USD | 3.82% |
| 2012 Q1 | 10.34 Million USD | 0.3% |
| 2011 Q4 | 10.31 Million USD | 0.56% |
| 2011 Q3 | 10.25 Million USD | 2.51% |
| 2011 Q1 | 9.55 Million USD | -2.2% |
| 2011 Q2 | 10 Million USD | 4.68% |
| 2011 FY | 40.12 Million USD | -8.69% |
| 2010 Q2 | 11.15 Million USD | -17.53% |
| 2010 Q1 | 13.52 Million USD | -1.19% |
| 2010 Q3 | 9.48 Million USD | -14.97% |
| 2010 Q4 | 9.77 Million USD | 3.0% |
| 2010 FY | 43.94 Million USD | -22.93% |
| 2009 Q1 | 14.31 Million USD | -3.45% |
| 2009 FY | 57.01 Million USD | -8.77% |
| 2009 Q2 | 14.74 Million USD | 2.98% |
| 2009 Q3 | 14.27 Million USD | -3.18% |
| 2009 Q4 | 13.69 Million USD | -4.06% |
| 2008 Q2 | 16.23 Million USD | 2.99% |
| 2008 Q3 | 15.67 Million USD | -3.47% |
| 2008 Q4 | 14.82 Million USD | -5.4% |
| 2008 FY | 62.49 Million USD | 13.11% |
| 2008 Q1 | 15.76 Million USD | 205.86% |
| 2007 Q3 | 34.73 Million USD | 92.78% |
| 2007 Q4 | -14.89 Million USD | -142.87% |
| 2007 Q2 | 18.01 Million USD | 3.64% |
| 2007 Q1 | 17.38 Million USD | 11.41% |
| 2007 FY | 55.24 Million USD | 8.79% |
| 2006 Q2 | 7.35 Million USD | -41.09% |
| 2006 Q1 | 12.48 Million USD | -1.42% |
| 2006 Q3 | 15.33 Million USD | 108.43% |
| 2006 Q4 | 15.6 Million USD | 1.77% |
| 2006 FY | 50.78 Million USD | 7.63% |
| 2005 Q3 | 13.15 Million USD | 20.02% |
| 2005 Q2 | 10.95 Million USD | 5.32% |
| 2005 Q1 | 10.4 Million USD | -4.8% |
| 2005 FY | 47.18 Million USD | 17.2% |
| 2005 Q4 | 12.66 Million USD | -3.68% |
| 2004 Q4 | 10.92 Million USD | -0.77% |
| 2004 Q1 | 8 Million USD | -2.19% |
| 2004 Q2 | 10.31 Million USD | 28.79% |
| 2004 Q3 | 11.01 Million USD | 6.82% |
| 2004 FY | 40.25 Million USD | 22.74% |
| 2003 Q3 | 8.38 Million USD | 5.39% |
| 2003 Q4 | 8.18 Million USD | -2.37% |
| 2003 Q1 | 8.27 Million USD | 5.61% |
| 2003 FY | 32.79 Million USD | 28.06% |
| 2003 Q2 | 7.95 Million USD | -3.89% |
| 2002 FY | 25.61 Million USD | 35.38% |
| 2002 Q2 | 5.73 Million USD | 3.35% |
| 2002 Q3 | 6.48 Million USD | 13.02% |
| 2002 Q1 | 5.55 Million USD | 9.77% |
| 2002 Q4 | 7.83 Million USD | 20.83% |
| 2001 FY | 18.91 Million USD | 16.04% |
| 2001 Q4 | 5.05 Million USD | 6.86% |
| 2001 Q3 | 4.73 Million USD | -2.87% |
| 2001 Q2 | 4.87 Million USD | 14.55% |
| 2001 Q1 | 4.25 Million USD | -22.67% |
| 2000 Q2 | 3.67 Million USD | 10.41% |
| 2000 Q1 | 3.32 Million USD | -30.57% |
| 2000 Q3 | 3.8 Million USD | 3.79% |
| 2000 FY | 16.3 Million USD | 24.56% |
| 2000 Q4 | 5.5 Million USD | 44.43% |
| 1999 Q2 | 2.8 Million USD | 3.7% |
| 1999 Q4 | 4.78 Million USD | 59.58% |
| 1999 FY | 13.08 Million USD | 48.72% |
| 1999 Q1 | 2.7 Million USD | -12.9% |
| 1999 Q3 | 3 Million USD | 7.14% |
| 1998 Q2 | 1.7 Million USD | -69.09% |
| 1998 FY | 8.8 Million USD | 49.15% |
| 1998 Q3 | 1.9 Million USD | 11.76% |
| 1998 Q1 | 5.5 Million USD | 19.57% |
| 1998 Q4 | 3.1 Million USD | 63.16% |
| 1997 Q2 | 4.1 Million USD | 32.26% |
| 1997 Q3 | 5 Million USD | 21.95% |
| 1997 FY | 5.9 Million USD | 247.06% |
| 1997 Q4 | 4.6 Million USD | -8.0% |
| 1997 Q1 | 3.1 Million USD | 34.78% |
| 1996 Q1 | 1.5 Million USD | -40.0% |
| 1996 Q4 | 2.3 Million USD | 21.05% |
| 1996 Q3 | 1.9 Million USD | 26.67% |
| 1996 FY | 1.7 Million USD | -22.73% |
| 1996 Q2 | 1.5 Million USD | 0.0% |
| 1995 Q2 | 2.4 Million USD | -4.0% |
| 1995 Q3 | 2.5 Million USD | 4.17% |
| 1995 FY | 2.2 Million USD | 175.0% |
| 1995 Q4 | 2.5 Million USD | 0.0% |
| 1995 Q1 | 2.5 Million USD | 0.0% |
| 1994 Q3 | 1.7 Million USD | 0.0% |
| 1994 FY | 800 Thousand USD | 300.0% |
| 1994 Q2 | 1.7 Million USD | 183.33% |
| 1994 Q1 | 600 Thousand USD | 0.0% |
| 1993 Q4 | 600 Thousand USD | 0.0% |
| 1993 Q2 | 600 Thousand USD | 0.0% |
| 1993 FY | 200 Thousand USD | 0.0% |
| 1993 Q3 | 600 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -103.324% |
| Prenetics Global Limited | 8.82 Million USD | -120.275% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -63.089% |
| CareDx, Inc | 178.32 Million USD | 89.093% |
| Exact Sciences Corporation | 1.84 Billion USD | 98.946% |
| Exagen Inc. | 29.45 Million USD | 33.969% |
| Inotiv, Inc. | 165.44 Million USD | 88.244% |
| Guardant Health, Inc. | 336.89 Million USD | 94.227% |
| Biodesix, Inc. | 36.07 Million USD | 46.088% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -1362.958% |
| Precipio, Inc. | 6.01 Million USD | -223.197% |
| iSpecimen Inc. | 5.1 Million USD | -280.782% |
| Natera, Inc. | 492.74 Million USD | 96.053% |
| Aspira Women's Health Inc. | 5.26 Million USD | -269.631% |
| Standard BioTools Inc. | 50.45 Million USD | 61.447% |
| 23andMe Holding Co. | 99.37 Million USD | 80.428% |
| Castle Biosciences, Inc. | 174.8 Million USD | 88.873% |
| Personalis, Inc. | 18.2 Million USD | -6.821% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -47.707% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -251.5% |
| OpGen, Inc. | -90.69 Thousand USD | 21545.741% |
| T2 Biosystems, Inc. | -8.17 Million USD | 338.066% |
| Myriad Genetics, Inc. | 476.4 Million USD | 95.917% |
| ICON Public Limited Company | 1.81 Billion USD | 98.928% |
| NeoGenomics, Inc. | 244.6 Million USD | 92.048% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -63.089% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 99.112% |
| RadNet, Inc. | 93 Million USD | 79.086% |
| MDxHealth SA | 43.92 Million USD | 55.724% |
| Psychemedics Corporation | 8.41 Million USD | -131.19% |
| Illumina, Inc. | 2.74 Billion USD | 99.291% |
| Check-Cap Ltd. | -212 Thousand USD | 9274.528% |
| Twist Bioscience Corporation | 133.34 Million USD | 85.414% |
| DarioHealth Corp. | 5.98 Million USD | -225.033% |
| Fulgent Genetics, Inc. | 104.45 Million USD | 81.38% |
| Sera Prognostics, Inc. | 96 Thousand USD | -20160.417% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 7161.147% |
| OPKO Health, Inc. | 318.12 Million USD | 93.886% |
| Medpace Holdings, Inc. | 524.5 Million USD | 96.292% |
| Neogen Corporation | 463.9 Million USD | 95.807% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -1264.313% |
| Prenetics Global Limited | 8.82 Million USD | -120.275% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -3716.277% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -2357.002% |
| Neuronetics, Inc. | 51.7 Million USD | 62.383% |
| Sotera Health Company | 577.15 Million USD | 96.63% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -2357.002% |